Replies to post #36978 on Biotech Values

[randychub]

Kosp $78 - Yeah I was going to invest in a company that makes carnitine, but I did not want to be so greedy.

Seriously would anyone have thought off investing in a company who's primary product was vitamin b3.

R

[donotknowityet]

Based on this logic MCU should get twice as much.
They work with B6 coenzyme Pyridoxal-5-phosphate.
They target only acute and chronic heart problems, cholesterol, high blood pressure and diabetes. They also said from the beginning that they micmic KOSP's business plan.
I think the double is a modest goal.